Saturated 1,4-diazo heterocycles including piperazines, 1,4-diazepanes, and 1,4-diazocanes, are highly important for therapeutic development, but their syntheses are often tedious. We describe here an amphoteric diamination strategy to unite readily available 1,2-, 1,3- or 1,4-diamine derivatives with electron-deficient allenes via a formal [n + 2] (n = 4, 5, 6) cyclization mode to produce the corresponding 1,4-diazo heterocycles in just one step. This strategy features mild reaction conditions, high functional group tolerance, and scalability (gram scale). The reagents used are cheap and readily available and no transition metal catalysts are needed. More sophisticated products containing trifluoromethyl group or bicyclic ring systems can be accessed via a one-pot procedure as well. Our mechanistic studies support that formation of mono-iodinated or chlorinated diamine intermediates is important for the desired transformation and the commonly proposed chloride-iodide exchange process and a radical N−C bond formation is unlikely when the combination of NCS/KI is used.
More than half of the FDA-approved small-molecule therapeutics contain at least one N-heterocyclic ring. Among these N-heterocycles, saturated N-heterocycles are indispensable in drug discovery1,2. For example, piperidine and piperazine rank the first and third most common N-heterocycles appearing in small-molecule drugs, respectively. Over 60 FDA approved drugs contain a piperazine ring, several of which are within the top 100 best-selling pharmaceutical products. Structurally, piperazine features a six-membered ring with two nitrogen atoms in 1,4-relationship. This structural feature provides large polar surface area and relative structural rigidity. The piperazine moiety can often function as both hydrogen bond acceptor and donor and lead to improved potency, selectivity, water solubility, oral bioavailability, and ADME (absorption, distribution, metabolism, and excretion) properties3. Similarly, other 1,4-diazo heterocycles such as 1,4-diazepanes and 1,4-diazocanes are important structural motifs in bioactive molecules. Saturated 1,4-diazepane backbone has already emerged in several important FDA-approved small-molecule drugs4,5,6. However, most of the 1,4-diazo heterocycle-containing molecules, particularly piperazine-containing drugs, only have substitutions on one or both of the nitrogen atoms and the piperazine moiety is used as a linker to connect two portions for target binding or as an appendage to tune physicochemical properties. Only a small percentage of them have substitutions on the carbon atoms of the 1,4-diazo heterocycle and these substitutions are usually limited to methyl, aryl, or carboxylate groups. Therefore, there is lack of carbon-substitution diversity on these 1,4-diazo heterocycle scaffold in modern drug discovery and this is mainly due to the scarcity of available synthetic methods to efficiently provide carbon-substituted 1,4-diazo heterocycles with high regio-, stereo- and/or enantio-selectivity7,8,9.
So far, the most commonly used approaches to synthesize piperazines are the reduction of (di)ketopiperazines and stepwise N-alkylation of 1,2-diamines10,11,12,13. These methods generally use amino acids and 1,2-diamines as starting materials and require multiple steps. Therefore, the carbon-substitution pattern highly depends on the starting material availability. Recently, transition metal including Pd-14,15,16,17,18, Au-19, Zr-20, and Ir21-catalyzed amination cyclization methods have been developed to synthesize piperazines. These methods need to use precious and often air and moisture sensitive heavy metal catalysts and are very substrate dependent. Notably, a series of stannyl amine protocol (SnAP) reagents have been developed by Bode and co-workers to enable efficient and modular access of N-heterocycles including piperazines22,23,24,25. One limitation for the SnAP method is the involvement of toxic tin reagents which is partially solved by their development of a series of silicon amine protocol (SLAP) reagents26. Zhou and co-workers have developed an asymmetric reduction of pyrazine derivatives to provide substituted piperazine products in high enantioselectivity27,28. In this case, the pyrazine starting materials need to be pre-activated first. An appealing strategy to introduce substituents on piperazine is direct C−H functionalization29. Unfortunately, most of the available methods for α-C−H functionalization of amines including piperidines and pyrrolidines failed miserably on piperazine substrates due to the existence of the second nitrogen, which either creates various side reactions including elimination and dehydrogenation or diminishes the reactivity of the α-C−H bond and/or the catalyst used30,31. Progress has been made in direct α-C−H lithiation-trapping protocol of N-Boc-protected piperazines, but the reaction conditions are generally harsh and the results are highly substrate dependent32. Recently, pioneered by MacMillan and co-workers, direct α-C−H functionalization of piperazines via photoredox catalysis has emerged as a promising method33,34,35. In addition to transition metal catalysis, an interesting phosphine-catalyzed umpolung addition and intramolecular conjugative addition strategy has been developed by the Lu group to synthesize piperazines and 1,4-diazepanes. In this case, only symmetrical 1,2- or 1,3-diamine derivatives (tosyl sulfonamides) were explored36. In general, the syntheses of 1,4-diazepanes and 1,4-diazocanes are also very limited and far less studied than the piperazines37,38,39. 1,4-Diazocanes present an even higher level of synthetic challenge due to the existence of a strained eight-membered ring. Overall, there is a strong need for efficient and selective synthesis of substituted piperazines, 1,4-diazepanes and 1,4-diazocanes in order to unleash their full potential in novel therapeutic development.
We wondered whether an amphoteric diamination reagent 1 would undergo cyclization with an unsaturated π-system 2 via a formal [n + 2] (n = 4, 5, 6) cyclization process to produce piperazine (3), 1,4-diazepane (4), and 1,4-diazocane (5) products in one step (Fig. 1). This amphoteric diamination strategy, once successfully developed, would provide rapid access to these privileged saturated N-heterocyclic structures and significantly enrich the toolbox of both medicinal chemists and synthetic chemists. In principle, 1,n-diamine (n = 2, 3, 4) derivative 6 could be viewed as an amphoteric reagent. In 6, the two nitrogen atoms are electronically differentiated. Deprotonation of the blue nitrogen would generate the nucleophilic nitrogen species and the red halogen-amine (chloro-, bromo- or iodo-amine) or O-benzoyl hydroxylamine would function as the electrophilic part. Amphoteric reagent 6 could be synthesized or generated in situ readily from the 1,n-diamine (n = 2, 3, 4) 7 via selective halogenation or oxidation of the red nitrogen. Herein, we report our initial discovery in developing a transition-metal-free intermolecular amphoteric diamination of allenes to synthesize a wide range of carbon-substituted piperazines, 1,4-diazepanes, and 1,4-diazocanes in one step. This enabling method features mild reaction conditions and cheap and readily available reagents. The primary cyclization product 9 can be converted to more sophisticated product by exploiting the rich chemistry of its enamine moiety.
Optimization of reaction conditions
Our investigation of the amphoteric diamination of allenes (Fig. 1c) started with chloroamine sulfonamide 11a (Table 1) which was synthesized from selective chlorination of the more electron-rich alkylamine of 11 in presence of a more electron deficient sulfonamide. Chloroamine sulfonamide 11a can be purified on silica gel column and stored in refrigerator for several months. Since copper catalyst has often been used in catalyzing electrophilic amination reactions40,41, we first treated a mixture of chloroamine sulfonamide 11a and allenyl ester 12 (1.5 equiv.) with 10% CuI and Cs2CO3 (1.5 equiv.) in THF at room temperature (Table 1, entry 1). To our delight, cyclized vinylogous amide product 13 was obtained in 20% yield surprisingly as a single regioisomer. Since vinylogous amide 13 is not stable on silica gel, a one-pot reduction was conducted to convert it to piperazine 14. No product 13 was observed without CuI (Table 1, entry 2), which indicates the importance of CuI. With this encouraging result, we investigated various copper catalysts, ligands, and other reaction parameters, but failed to improve the reaction yield. We then switched CuI to KI (0.2 equiv.) and desired product 13 was obtained in 35% yield (Table 1, entry 3). It turned out that iodide was catalyzing this transformation, not the copper part. Once we realized this key point, we quickly optimized the reaction conditions by simply increasing the amount of KI (Table 1, entries 4–6) and product 13 was produced in 79% yield with either 1.0 or 2.0 equiv. of KI. Other iodide salts such as NaI and tetrabutylammonium iodide (TBAI) are less effective than KI (Table 1, entries 8, 9). THF was approved to be superior to CH3CN (Table 1, entry 7) and other solvents and increasing the reaction temperature to 40 °C did not improve the reaction yield (Table 1, entry 10). Since chloroamine sulfonamide 11a was produced simply by chlorination of 11 with N-Chlorosuccinimide (NCS), we explored the possibility of in situ generation of 11a (Table 1, entry 11). This approach was effective to produce 13 in 79% yield. We speculated that the role of KI was presumably to generate a more reactive iodoamine via an iodide-chloride exchange42, which turned out not to be the case as we carried on this research further. Therefore, we replaced the combination of NCS/KI with N-Iodosuccinimide (NIS) (Table 1, entry 12). Satisfyingly, product 13 was obtained in 86% yield and a one-pot reduction gave piperazine 14 in 70% yield. Notably, this one-pot procedure can be scaled up to produce 14 in 76% yield at gram scale (Table 1, entry 13).
Substrate scope for the synthesis of piperazines
With the optimized reaction conditions in hand, the scope study of both the 1,2-diamines and allenes was subsequently conducted (Table 2). The one-pot amphoteric diamination procedure was approved to be very general in preparing various carbon-substituted piperazine products. Different 1,2-diamine derivatives underwent cyclization with allenyl ester 12 to give the desired piperazine products (19–57) which can also be viewed as β,γ-amino acid derivatives. Functional groups including bromide (28, 29), CF3 (21), NO2 (23), free alcohol (39), Boc-carbamate (40), olefin (44), cyclopropyl group (41), and heteroaromatics (30–35, 45, 51, 58) such as quinonine, pyridine, furan, pyrrole, indole, and thiophene are all well tolerated under the mild reaction conditions. The tosyl group can be switched to other sulfonamide groups (45–52) including the readily removable nosyl group (48–50). In addition to other allenyl esters (53–57), allenyl ketone (58–64), nitrile (65), sulfone (66), phosphine oxide (67), and phosphanate (68) can be used as the unsaturated π-system for the amphoteric diamination cyclization to afford piperazines with a diverse substituents on C2. The introduction of sulfone, phosphine oxide, and phosphanate into the piperazine products offers opportunities for further structural diversifications via various olefination reactions.
Piperazines with more than one carbon-substitutions can be produced as well (69–81). Notably, for the case of 2,6-disubstituted piperazines, after the one-pot NaBH3CN reduction, instead of getting the 2,6-cis products with two equatorial substituents, which are often produced as the predominant products especially with nitrogen-unprotected cases43, the more challenging 2,6-trans substituted products were obtained as the major products (69, 70; dr > 15:1). The trans-selectivity observed in the above reduction is presumably due to an axial hydride attack on the iminium ion intermediate formed under acidic conditions. Iminium ion conformer 70a is favored over 70b because the latter suffers from strong steric interaction between the C-Me and N-Me groups (A1,2 type interaction)44. An axial hydride attack on 70a delivers the 2,6-trans substituted product as the major stereoisomer. For the case of 2,5-substituted piperazines, instead of getting the 2,5-trans substitution patterns where the two substituents are equatorially oriented, 2,5-cis substituted products were obtained in our cases (71–76, 79, 80). Based on the crystal structures of 71 and 75′, an intermediate we isolated before NaBH3CN reduction (the corresponding primary amphoteric cyclization product isomerized to 75′ on silica gel column), we hypothesized that the phenyl group in iminium ion intermediate 75a prefers to occupy the axial position to avoid strong steric repulsion with the tosyl group and an axial delivery of the hydride provides the 2,5-cis product as the dominant stereoisomer. These results enable ready access of 2,6-trans or 2,5-cis substituted piperazines, which are otherwise challenging to synthesize. Interestingly, for the cases of bicyclic piperazine products 77, 78 and 81, the major products (dr > 15:1) turned out to have a 2,6-cis and/or 2,5-trans stereochemical relationship. In these cases, the bicyclic ring systems locked the conformation and an axial hydride attack gave the major product. The relative stereochemistry of 70, 71, 76, 77, and 81 were unambiguously established by X-ray crystallography of themselves (70, 71, 77) or their derivatives (76, 81, see the Supplementary Figs. 1 and 2).
Scope for the synthesis of 1,4-diazepanes and 1,4-diazocanes
We then explored the possibility of expanding the amphoteric diamination cyclization strategy to synthesize 1,4-diazepanes and 1,4-diazocanes with readily available 1,3- or 1,4-diamine derivatives (Table 3). With the NIS reaction conditions at an elevated reaction temperature (60 °C, Conditions A), 1,4-diazepane products 86–102 were produced smoothly in modest to good yield. For the products containing an all-carbon quaternary center (103–106), the combination of NCS (1.05 equiv.) and KI (2.0 equiv.) at 60 °C (Conditions C) is superior to the NIS conditions. For the case of 1,4-diazocane synthesis, a highly strained eight-membered ring needs to be constructed and it has been a long standing synthetic challenge. It turned out that the amphoteric diamination cyclization strategy is highly efficient for this task. Simply heating the mixture of mono-N-iodinated 1,4-diamines generated in situ with NIS treatment and the corresponding allene substrates at 100 °C followed by one-pot reduction, desired 1,4-diazocanes were produced in modest to good yield (107–116). For the syntheses of 1,4-diazepanes and 1,4-diazocanes, like the case of piperazine synthesis, allenyl ester (86–97, 103–107, 112–115), ketone (100), nitrile (98, 116), sulfone (102, 108–111), phosphine oxide (99), and phosphanate (101) are all effective substrates. Despite the elevated reaction temperatures, a broad range of functional groups are tolerated. The necessity of an elevated reaction temperature is presumably due to the difficulties involved in closing the seven- or eight-membered ring systems. The amphoteric iodoamine intermediates derived from 1,4-diamines are believed to have lower reactivity in comparison to the ones derived from 1,2- and 1,3-diamines presumably due to the weakened or lack of intramolecular hydrogen bonding interaction between the sulfonamide hydrogen atom and the iodoamine nitrogen atom.
Diversification of the vinylogous amide products
Instead of directly reducing the vinylogous amide products generated from the amphoteric diamination cyclization of allenes, we further explored the possibility of harnessing their intrinsic reactivity to introduce other substituents and/or to increase product structural complexity. Due to the importance of trifluoromethyl (CF3) group in medicinal chemistry and the current synthetic challenges of installing CF3 at the α-position of piperazines45, we started to develop a protocol to synthesize α-CF3-substituted piperazines (Fig. 2a). After the formation of the crude primary vinylogous amide product 13, trifluoromethanesulfonic acid (TfOH) was used to isomerize the vinylogous amide to an iminium intermediate, which was then trapped by a nucleophilic addition of trifluoromethyl anion derived from a combination of KHF2 and the Ruppert−Prakash reagent TMSCF3. Desired product 117 was obtained in 42% yield from 11. On the other hand, the vinylogous amide products 120 or 121 synthesized from the amphoteric diamination cyclization of 118 or 119 with allene 12 can be readily converted to a 6,6- or 6,7-fused bicyclic product (122 or 123) in 54 or 42% yield, respectively, via an intramolecular Mannich-type reaction (Fig. 2b). These two diversification reactions demonstrate the synthetic potential of the amphoteric diamination cyclization of allenes to synthesize complex N-heterocycles and highlight the advantages of using allene substrates.
Removal of tosyl and nosyl groups
While sulfonamides prevalently exist in many drug molecules and other biofunctional molecules, it would significantly enhance the impact of the amphoteric diamination cyclization strategy in medicinal chemistry if the sulfonamide groups such as tosyl and nosyl groups can be removed easily to allow further functionalization of these privileged N-heterocycles. We have successfully demonstrated that both the tosyl and nosyl groups can be removed readily (Fig. 3). For example, upon treatment of piperazine 20 with MeSO3H in a mixture of trifluoroacetic acid (TFA) and thioanisole, desired product 124 was obtained in 76% yield46. The nosyl group of 1,4-diazepane 90 can be removed under basic conditions (Cs2CO3) with PhSH as nucleophile and product 125 was obtained in 80% yield47. The ease of removing both the tosyl and nosyl group enables the introduction of other functionalities on the nitrogen atoms, which carries important value in applying this method in medicinal chemistry.
To provide insights about the reaction mechanism of this amphoteric diamination cyclization, we first used ESI-MS to monitor the reaction process. The reaction between 11 and 12 was studied under both the NIS and NCS/KI reaction conditions (Fig. 4 and Supplementary Figs. 3−6). Upon the treatment of 11 with NIS, we observed the formation of iodoamine 11b ([M + H]+: 397.1), but it cannot be isolated due to its instability under light and heat and on silica gel column. After introduction of allene 12 and Cs2CO3 to 11b, the formation of an iodide intermediate with molecular weight of 508.1 was observed. This iodide intermediate was tentatively assigned as 126 or 127, which cannot be differentiated by the ESI MS data. We also tried to isolate these two proposed allylic iodide intermediates, but these attempts were unsuccessful due to their high reactivity despite their clear existence in the ESI-MS systems. Longer reaction time led to the formation of 13, observed at 381.3 ([M+H]+) or 513.2 [M+Cs]+, via a substitution process to form the second carbon−nitrogen bond and closed the six-membered ring. An aziridinium ion intermediate is unlikely to be involved in the ring closing process, but cannot be ruled out completely at this stage. Interestingly, when N-chloroamine 11a, which is bench stable and can be isolated as a white solid, was treated with KI, we did not observe the formation of 11b via the ESI-MS study, but 126 or 127 was observed upon the treatment with KI, 12, and Cs2CO3. This result suggests that the formation of 126 or 127 from a combination of 11/NIS or 11/NCS/KI might occur via different reaction mechanisms and chloroamine 11a did not undergo a simple chloride-iodide exchange process to form iodoamine 11b while such chloride-iodide exchange process is commonly proposed in literature 42,48.
The detailed mechanism for the formation of the first carbon−nitrogen bond has not been well understood yet. This net addition of an iodo/chloroamine to the double bond of an allene substrate might go through a stepwise radical process50,51, a concerted process, or a stepwise ionic process52,53 (Fig. 5). Both the radical process and ionic process have been proposed for the reactions of N-iodo/chloroamine with olefins. In our case, a radical process would involve a homolytic cleavage of the N-I/Cl bond of 11b/11a to generate nitrogen radical 128, which would add on the sp carbon of allene 12 to form an allylic radical. The latter would be trapped by iodide to produce allylic iodide 126/127 (Fig. 5a). A concerted mechanism resembling the hydroboration process via a four-membered ring transition state (130 or 131) would give 126/127 as well (Fig. 5b). In this case, the more nucleophilic nitrogen atom would align up with the sp carbon of allene 12 to give the observed regiochemistry. Additionally, stepwise ionic process could be operational (Fig. 5c–e). For example, the iodoamine (11b) or chloroamine (11a) nitrogen could use its electron pair to undergo nucleophilic attack on the sp carbon of allene 12 to form 132 or 133 respectively. For 132, an intramolecular or intermolecular I+ shift could happen to lead to 126/127 (Fig. 5c); for 133, iodide from KI could pick up the chloride to form ICl, which could in turn serve as the I+ source to form 126/127 (Fig. 5d). A three-membered iodonium ion intermediate (134, Fig. 5e) generated from reacting iodoamine with allene 12 is unlikely because 12 is electron deficient and the nucleophilic ring opening step would prefer to attack the terminal carbon (path b) to give the opposite regioselectivity as observed.
To probe the addition process of N-iodo/chloroamine to allene substrate such as 12, we prepared 1,2-diamine derivative 135 containing a vinyl cyclopropane moiety, a commonly used radical clock (Fig. 6a). When 135 was treated with the NIS reaction conditions, the reaction turned out to be quite complex and we did not observe the formation of desired piperazine product 136; instead the formation of pyrrolidine product 137 was observed. We then removed the NaBH3CN reduction step and were able to identify 137 as the major product in 37% yield from a complex mixture (Fig. 6b). The structure of 137 was unambiguously confirmed by X-ray crystallographic analysis. The formation of 137 is presumably via an NIS promoted intramolecular iodoamination cyclization followed by replacement of the resulting iodide with succinimide. NIS could activate the cis-double bond directly or it could iodinate the secondary alkyl amine first and the resulting iodoamine would activate the double bond via an intramolecular I+ transfer process54. Interestingly, when we switched the NIS conditions to the NCS/KI conditions, desired piperazine product 136 was obtained as the major product in 47% yield along with 137 in 15% yield (Fig. 6c). Again, these results indicate that the reaction mechanism for the amphoteric diamination cyclizations under the NIS conditions is different from the ones under the NCS/KI conditions. The latter might involve the formation of iodine monochloride (ICl, Fig. 5d). Why the NCS/KI conditions are able to produce 136 and suppress the formation of 137 requires further investigation. Similar results were observed when substrate 138 was used. The NIS conditions gave a complex mixture, but the NCS/KI conditions provided desired product 139 in 38% (Fig. 6d). The formation of both 136 and 139 under the NCS/KI conditions suggests that a radical mechanism to form allylic iodide intermediates such as 126/127 observed in ESI-MS is unlikely because the nitrogen radical can be readily intercepted by the intramolecularly tethered olefins via a 5-exo-trig cyclization process.
Additionally, in order to explore the roles of NIS and NCS/KI in these transformations, a few more experiments were explored (Fig. 7). First, a reaction between diamine 140 and allene 12 was conducted under basic conditions (Cs2CO3) in THF at room temperature. The formation of mono- and bis-nucleophilic addition products 142 and 141 were observed by 1H NMR analysis of the reaction mixture, which was further confirmed by a one-pot reduction of the corresponding vinylogous amide intermediates to 144 and 143, respectively (Fig. 7a). Further treatment of the reaction mixture of 140 and 12 with NIS or ICl followed by NaBH3CN reduction did not result in the formation of 20, but 143 in 33 or 27% yield, respectively (Fig. 7b). This result ruled out the possibility of 142 as a potential intermediate for the formation of 20. Since ICl was proposed as a plausible intermediate when the combination of NCS/KI was employed, we used it to replace NIS and NCS/KI for the reaction of 140 with 12 and desired product 20 was formed in 13% yield along with 144 in 31% yield (Fig. 7c), which suggests that ICl is not as good as NIS or NCS to generate the corresponding iodo or chloroamine intermediate. This notion was corroborated by the fact that an unidentifiable mixture was generated when 140 was treated with ICl in THF-d8, but clear formation of the iodoamine intermediate was observed by 1H NMR analysis when NIS was used (Supplementary Fig. 7). Additionally, pre-treatment of allene 12 with NIS for 1 h before the addition of 140 or simply adding 12, NIS and 140 at the same time was able to produce 20 in 53 or 56% yield, respectively, which is slightly lower than the yield (62%) of pre-treatment of 140 with NIS for 1 h before the addition of 12 (Table 2 and Fig. 7d). Interestingly, while pre-treatment of 140 with ICl for 1 h before the addition of 12 or pre-treatment of 12 with ICl for 1 h before the addition of 140 could form 20 in 13 or 15% yield, respectively, the operation of simply mixing 12, ICl and 140 at the same time only afforded a trace amount of 20 (~2%). Our 1H NMR experiments showed that 12 did not react with NIS or ICl in THF-d8 after 1 h (Fig. 7e and Supplementary Fig. 8) and ICl reacted with THF solvent to produce a new product, which might be a THF polymerization or ring opening product, but need more experiments to elucidate. Overall, these experiments indicate that the successful formation of iodo or chloroamine intermediates is important for the desired amphoteric diamination and whether or not ICl is involved when NCS/KI was used remains unanswered.
In summary, an amphoteric diamination strategy has been developed to rapidly synthesize medicinally important carbon-substituted 1,4-diazo heterocycles including piperazines, 1,4-diazepanes, and 1,4-diazocanes. These N-heterocycles are otherwise difficult to access. This highly modular and convergent strategy utilizes readily available 1,2-, 1,3- or 1,4-diamine derivatives and electron-deficient allenes as the two coupling partners, which are assemble into saturated 1,4-diazo heterocycles via a formal [n + 2] (n = 4, 5, 6) cyclization mode. It does not require any precious transition metal catalysts. The reagents used are cheap and the reaction features mild reaction conditions, high functional group tolerance, and scalability (gram scale). In addition to a direct one-pot reduction, the vinylogous amide products can be converted to more complex products including α-CF3 substituted product and bicyclic products via a trifluoromethyl addition or an intromolecular Mannich-type reaction, respectively. We also demonstrated that both the tosyl group and nosyl group could be removed readily to allow further functionalization of the nitrogen atoms. Given the prestigious importance of these saturated N-heterocycles in medicines, the transformations reported here are expected to have broad applications in novel therapeutic discovery and development processes. Our current mechanistic studies showed that the formation of mono-iodinated or chlorinated amphoteric diamine intermediates is important for the success of the desired cyclization and a commonly proposed chloride-iodide exchange process and a radical N−C bond formation is unlikely when the combination of NCS/KI is used. Further detailed mechanistic studies and developing an enantioselective version of this reaction are currently undergoing in our laboratory.
General procedure for piperazine synthesis
To a 2-dram vial wrapped with aluminum foil was added a 1,2-diamine substrate (0.1 mmol), NIS (0.105 mmol), and dry THF (1 mL). The reaction mixture was stirred for 1 h under argon before an allene substrate (0.15 mmol) and Cs2CO3 (0.15 mmol) was added. After the reaction mixture was stirred for 24 h, NaBH3CN (0.2 mmol) and a co-solvent of MeOH/AcOH (pH = 4, 1 mL) were added to the reaction mixture. After 3 h, the reaction was quenched with a saturated aqueous solution of NaHCO3, extracted with CH2Cl2 for three times. The combined organic extracts were dried over Na2SO4 and concentrated in vacuo. The crude mixture was purified on silica gel column with hexane/EtOAc as eluents to give the desired piperazine product.
The X-ray crystallographic coordinates for the structures of 70 (CCDC 1561430), 71 (CCDC 1561427), 77 (CCDC 1561428), 75′ (CCDC 1583717), 137 (CCDC 1582123), a derivative of 76 (CCDC 1561429), and a derivative of 81 (CCDC 1561431) reported in this article have been deposited at the Cambridge Crystallographic Data Centre (CCDC). The data can be obtained free of charge from the Cambridge Crystallographic Data Centre via http://www.ccdc.cam.ac.uk/data_request/cif. The authors declare that the data supporting the findings of this study are available within the article and its Supplementary Information Files. All other data are available from the authors upon reasonable request.
Taylor, R. D., MacCoss, M. & Lawson, A. D. G. Rings in drugs. J. Med. Chem. 57, 5845–5859 (2014).
Zhang, T. Y. The evolving landscape of heterocycles in drugs and drug candidates. Adv. Heterocycl. Chem. 121, 1–12 (2017).
Walker, M. A. Novel tactics for designing water-soluble molecules in drug discovery. Expert Opin. Drug Discov. 9, 1421–1433 (2014).
Murota, H. & Katayama, I. Emedastine difumarate: a review of its potential ameliorating effect for tissue remodeling in allergic diseases. Expert Opin. Pharmacother. 10, 1859–1867 (2009).
Kuriyama, A. & Tabata, H. Suvorexant for the treatment of primary insomnia: a systematic review and meta-analysis. Sleep Med. Rev. 35, 1–7 (2016).
Feng, Y., LoGrasso, P. V., Defert, O. & Li, R. Rho kinase (ROCK) inhibitors and their therapeutic potential. J. Med. Chem. 59, 2269–2300 (2016).
Vitaku, E., Smith, D. T. & Njardarson, J. T. Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals. J. Med. Chem. 57, 10257–10274 (2014).
Gettys, K. E., Ye, Z. & Dai, M. Recent advances in piperazine synthesis. Synthesis (Mass). 49, 2589–2604 (2017).
Vo, C.-V. T. & Bode, J. W. Synthesis of saturated N-heterocycles. J. Org. Chem. 79, 2809–2815 (2014).
Dinsmore, C. J. & Beshore, D. C. Syntheses and transformations of piperazinone rings. Org. Prep. Proced. Int. 34, 367–404 (2002).
Yar, M., McGarrigle, E. M. & Aggarwal, V. K. An annulation reaction for the synthesis of morpholines, thiomorpholines, and piperazines from β-heteroatom amino compounds and vinyl sulfonium salts. Angew. Chem. Int. Ed. 47, 3784–3786 (2008).
Periasamy, M., Edukondalu, A. & Reddy, P. O. Synthesis of chiral 2,3-disubstituted 1,4-diazabicyclo[2.2.2]octane derivatives. J. Org. Chem. 80, 3651–3655 (2015).
O’Reilly, M. C. & Lindsley, C. W. A general, enantioselective synthesis of protected morpholines and piperazines. Org. Lett. 14, 2910–2913 (2012).
Korch, K. M. et al. Enantioselective synthesis of α-secondary and α-tertiary piperazin-2-ones and piperazines by catalytic asymmetric allylic alkylation. Angew. Chem. Int. Ed. 54, 179–183 (2015).
Nakhla, J. S. & Wolfe, J. P. A concise asymmetric synthesis of cis-2,6-disubstituted N-aryl piperazines via Pd-catalyzed carboamination reactions. Org. Lett. 9, 3279–3282 (2007).
Cochran, B. M. & Michael, F. E. Synthesis of 2,6-disubstituted piperazines by a diastereoselective palladium-catalyzed hydroamination reaction. Org. Lett. 10, 329 (2008).
Lu, Z. & Stahl, S. S. Intramolecular Pd(II)-catalyzed aerobic oxidative amination of alkenes: synthesis of six-membered N-heterocycles. Org. Lett. 14, 1234–1237 (2012).
Montgomery, T. D. & Rawal, V. H. Palladium-catalyzed modular synthesis of substituted piperazines and related nitrogen heterocycles. Org. Lett. 18, 740–743 (2016).
James, T., Simpson, I., Grant, J. A., Sridharan, V. & Nelson, A. Modular, gold-catalyzed approach to the synthesis of lead-like piperazine scaffolds. Org. Lett. 15, 6094–6097 (2013).
Zhai, H., Borzenko, A., Lau, Y. Y., Ahn, S. H. & Schafer, L. L. Catalytic asymmetric synthesis of substituted morpholines and piperazines. Angew. Chem. Int. Ed. 51, 12219–12223 (2012).
Lorentz-Petersen, L. L. R., Nordstrøm, L. U. & Madsen, R. Iridium-catalyzed condensation of amines and vicinal diols to substituted piperazines. Eur. J. Org. Chem. 2012, 6752–6759 (2012).
Luescher, M. U., Vo, C.-V. T. & Bode, J. W. SnAP reagents for the synthesis of piperazines and morpholines. Org. Lett. 16, 1236–1239 (2014).
Geoghegan, K. & Bode, J. W. Bespoke SnAP reagents for the synthesis of C-substituted spirocyclic and bicyclic saturated N-heterocycles. Org. Lett. 17, 1934–1937 (2015).
Leuscher, M. U. & Bode, J. W. Catalytic synthesis of N-unprotected piperazines, morpholines, and thiomorpholines from aldehydes and SnAP reagents. Angew. Chem. Int. Ed. 54, 10884–10888 (2015).
Siau, W.-Y. & Bode, J. W. One-step synthesis of saturated spirocyclic N-heterocycles with stannyl amine protocol (SnAP) reagents and ketones. J. Am. Chem. Soc. 136, 17726–17729 (2014).
Hsieh, S.-Y. & Bode, J. W. Silicon amine reagents for the photocatalytic synthesis of piperazines from aldehydes and ketones. Org. Lett. 18, 2098–2101 (2016).
Huang, W.-X., Liu, L.-J., Feng, G.-S., Wang, B. & Zhou, Y.-G. Synthesis of chiral piperazines via hydrogenation of pyrazines activated by alkyl halides. Org. Lett. 18, 3082–3085 (2016).
Huang, W.-X., Yu, C.-B., Shi, L. & Zhou, Y.-G. Iridium-catalyzed asymmetric hydrogenation of pyrrolo[1,2-a]pyrazinium salts. Org. Lett. 16, 3324–3327 (2014).
Ye, Z., Gettys, K. E. & Dai, M. J. Opportunities and challenges for direct C−H functionalization of piperazines. Beilstein J. Org. Chem. 12, 702–715 (2016).
Gribkov, D. V., Pastine, S. J., Schnürch, M. & Sames, D. Ruthenium catalyzed decarbonylative arylation at sp3 carbon centers in pyrrolidine and piperidine heterocycles. J. Am. Chem. Soc. 129, 11750–11755 (2007).
Ishii, Y., Chatani, N., Kakiuchi, F. & Murai, S. Rhodium-catalyzed reaction of N-(2-pyridinyl)piperazines with CO and ethylene. A novel carbonylation at a C−H bond in the piperazine ring. Organometallics 16, 3615–3622 (1997).
Firth, J. D., O’Brien, P. & Ferris, L. Synthesis of enantiopure piperazines via asymmetric lithiation-trapping of N-Boc piperazines: unexpected role of the electrophile and distal N-substituent. J. Am. Chem. Soc. 138, 651–659 (2016).
McNally, A., Prier, C. K. & MacMillan, D. W. C. Discovery of an α-amino C-H arylation reaction using the strategy of accelerated serendipity. Science 334, 1114–1117 (2011).
Noble, A. & MacMillan, D. W. C. Photoredox α-vinylation of α-amino acids and N-aryl amines. J. Am. Chem. Soc. 136, 11602–11605 (2014).
Prier, C. K. & MacMillan, D. W. C. Amine α-heteroarylation via photoredox catalysis: a homolytic aromatic substitution pathway. Chem. Sci. 5, 4173–4178 (2014).
Lu, C. & Lu, X. Tandem reactions to construct heterocycles via phosphine-catalyzed umpolung addition and intramolecular conjugate addition. Org. Lett. 4, 4677–4679 (2002).
Vo, C.-V. T., Leuschere, M. U. & Bode, J. W. SnAP reagents for the one-step synthesis of medium-ring saturated N-heterocycles from aldehydes. Nat. Chem. 6, 310–314 (2014).
James, T. et al. A modular lead-oriented synthesis of diverse piperazine, 1,4-diazepane and 1,5-diazocane scaffolds. Org. Biomol. Chem. 12, 2584–2591 (2014).
Crestey, F., Witt, M., Jaroszewski, J. W. & Franzyk, H. Expedite protocol for construction of chiral regioselectively N-protected monosubstituted piperazine, 1,4-diazepane, and 1,4-diazocane building blocks. J. Org. Chem. 74, 5652–5655 (2009).
Göttlich, R. Copper(I)-catalyzed intramolecular addition of N-chloroamines to double bonds under aprotic conditions. Towards a stereoselective catalytic radical reaction. Synthesis (Mass). 11, 1561–1564 (2000).
Pirnot, M. T., Wang, Y.-M. & Buchwald, S. L. Copper hydride catalyzed hydroamination of alkenesand alkynes. Angew. Chem. Int. Ed. 55, 48–57 (2016).
Noack, M. & Göttlich, R. Iodide-catalysed cyclization of unsaturated N-chloroamines: a new way to synthesise 3-chloropiperidines. Eur. J. Org. Chem. 2002, 3171–3178 (2002).
Ryckman, D. M. & Stevens, R. V. Stereoselective syntheses of cis-2-alkyl-6-methylpiperidines. J. Org. Chem. 52, 4274–4279 (1987).
Toyooka, N., Yoshida, Y., Yotsui, Y. & Momose, T. 2-Piperidone type of chiral building block for 3-piperidinol alkaloid synthesis. J. Org. Chem. 64, 4914–4919 (1999).
Sanchez-Rosello, M. et al. Diastereoselective synthesis of 2-phenyl-3-(trifluoromethyl)piperazines as building blocks for drug discovery. J. Org. Chem. 79, 5887–5894 (2014).
Yan, Z., Wu, B., Gao, X., Chen, M.-W. & Zhou., Y.-G. Enantioselective synthesis of α-amino phosphonates via Pd-catalyzed asymmetric hydrogenation. Org. Lett. 18, 692–695 (2016).
Mori, Y. et al. Synthesis and optimization of novel (3S,5R)-5-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)piperidine-3-carboxamides as orally active renin inhibitors. Bioorg. Med. Chem. 21, 5907–5922 (2013).
Ortiz, G. X., Kang, B. & Wang, Q. One-pot synthesis of 3-azido- and 3-aminopiperidines by intramolecular cyclization of unsaturated amines. J. Org. Chem. 79, 571–581 (2014).
Kovacic, P., Lowery, M. K. & Field, K. W. Chemistry of N-bromamines and N-chloramines. Chem. Rev. 70, 639–665 (1970).
Ibrahim, A. A., Golonka, A. N., Lopez, A. M. & Stockdill, J. L. Rapid access to the heterocyclic core of the calyciphylline A and daphnicyclidin A-type daphniphyllum alkaloids via tandem cyclization of a neutral aminyl radical. Org. Lett. 16, 1072–1075 (2014).
Shen, B., Makley, D. M. & Johnston, J. N. Umpolung reactivity in amide and peptide synthesis. Nature 465, 1027–1032 (2010).
Danneman, M. W., Hong, K. B. & Johnston, J. N. Oxidative inter-/intermolecular alkene diamination of hydroxy styrenes with electron-rich amines. Org. Lett. 17, 2558–2561 (2015).
Huang, H., Lacy, T. C., Blachut, B., Ortiz, G. & Wang, Q. An efficient synthesis of fluorinated azaheterocycles by aminocyclization of alkenes. Org. Lett. 15, 1818–1821 (2013).
We thank the NIH P30CA023168 for supporting shared NMR resources to Purdue Center for Cancer Research. The XRD data are collected on a new single crystal X-ray diffractometer supported by the NSF through the Major Research Instrumentation Program under Grant No. CHE 1625543. Y.X. acknowledges NIH R01GM118484 for financial support. M.D. thanks Eli Lilly for an unrestricted grant support via the 2017 Eli Lilly Grantee Award.
The authors declare no competing financial interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
About this article
Cite this article
Ye, Z., Adhikari, S., Xia, Y. et al. Expedient syntheses of N-heterocycles via intermolecular amphoteric diamination of allenes. Nat Commun 9, 721 (2018). https://doi.org/10.1038/s41467-018-03085-3
Trihaloisocyanuric acids in ethanol: an eco-friendly system for the regioselective halogenation of imidazo-heteroarenes
Green Chemistry (2020)
The Journal of Organic Chemistry (2020)
Organic & Biomolecular Chemistry (2020)
Biocatalytic Access to 1,4-Diazepanes via Imine Reductase-Catalyzed Intramolecular Asymmetric Reductive Amination
ACS Catalysis (2020)
Synthesis of 1,2,5‐Oxadiazinane Derivatives by Photochemical Cycloaddition of Nitrones with Diaminomethanes